Sushil Srivastava,
Process Research and Development Director
Dr. Sushil K. Srivastava is the Director of Chemical Development (Drug Substance), Pharmaceutical Development at Bristol-Myers Squibb (BMS). He is responsible for late phase development including QbD/PAT, technology transfer of drug substance processes to commercial manufacturing sites and providing source documents for CMC filings and responses to Health Authority questions. He received his Ph.D. degree in synthetic organic chemistry from Banaras Hindu University, Varanasi, India in 1978 and had post doctoral experience in physical organic chemistry with Prof. W. J. le Noble, State University of New York, Stony Brook, NY and E. C. Ashby, Georgia Tech at Atlanta, GA prior to joining BMS in 1987.
|
.jpg)
|
|
